Need for hospital admission in patients with ulcerative colitis during maintenance with azathioprine;Frequenza di ricovero ospedaliero nei pazienti con rettocolite ulcerosa grave durante terapia di mantenimento con azatioprina

Minerva Gastroenterologica e Dietologica

Volumn 50, Issue 1, 2004, Pages 97-101

  Actis, G C ^a   Rossetti, S ^a   Rizzetto, M ^a   Fadda, M ^a   Palmo, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Azathioprine; Colitis, ulcerative; Therapy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAY HOSPITAL; DISEASE COURSE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAINTENANCE THERAPY; MALE; REMISSION; RETROSPECTIVE STUDY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AZATHIOPRINE; COLITIS, ULCERATIVE; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED;

EID: 2442441947     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marion JF, Present DH. The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 1997;9:831-5.
2. Hanauer SB. Update on medical management of inflammatory bowel disease: ulcerative colitis. Rev Gastroenterol Disord 2001;1:169-76.
3. Present DH. Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomixed, double-blind study. N Engl J Med 1980;302:981-7.
4. Kamm MA. Review article: maintenance of remission in ulcerative colitis. Aliment Pharmacol Ther 2002;16 Suppl 4:21-4.
5. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30-year review. Gut 2002;50:485-9.
6. Hawthorne AB, Logan RFA, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J 1992;305:20-2.
7. Khan ZH, Mayberry JF, Spiers N, Wicks AC. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience. Digestion 2000;62:249-54.
8. Van Deventer SJH. The future of inflammatory bowel disease therapy. Inflamm Bowel Dis 2002;8:301-5.
9. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2:1041-8.
10. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60.
11. Hanauer SB. Update on medical management of inflammatory bowel disease: ulcerative colitis. Rev Gastroenterol Dis 2001;1:169-76.
12. Actis GC, Bresso F, Astegiano M, Demarchi B, Sapone N, Boscaglia C. Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther 2001;15: 1307-11.
13. Paoluzi OA, Pica R, Marcheggiano A, Crispino P, Iacopini F, Iannoni C et al. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission. Aliment Pharmacol Ther 2002;16:1751-9.
14. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects on cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988;23: 1147-52.
15. Sood A, Kaushal V, Midha V, Bhatia KL, Sood N, Malhotra V. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis. J Gastroenterol 2002;37:270-4.
16. Podolsky DK. Medical progress. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
17. Rubenstein JH, Chong RY, Cohen RD. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol 2002;35:151-6.